| Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF JP Bassand, G Accetta, AJ Camm, F Cools, DA Fitzmaurice, KAA Fox, ... European heart journal 37 (38), 2882-2889, 2016 | 297 | 2016 |
| Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation AJ Camm, G Accetta, G Ambrosio, D Atar, JP Bassand, E Berge, F Cools, ... Heart 103 (4), 307-314, 2017 | 291 | 2017 |
| Quality of vitamin K antagonist control and 1-year outcomes in patients with atrial fibrillation: a global perspective from the GARFIELD-AF registry S Haas, H Ten Cate, G Accetta, P Angchaisuksiri, JP Bassand, AJ Camm, ... PloS one 11 (10), e0164076, 2016 | 174 | 2016 |
| Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without … KAA Fox, JE Lucas, KS Pieper, JP Bassand, AJ Camm, DA Fitzmaurice, ... BMJ open 7 (12), e017157, 2017 | 141 | 2017 |
| Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: rationale for comprehensive management of atrial fibrillation JP Bassand, G Accetta, W Al Mahmeed, R Corbalan, J Eikelboom, ... PloS one 13 (1), e0191592, 2018 | 116 | 2018 |
| Early risks of death, stroke/systemic embolism, and major bleeding in patients with newly diagnosed atrial fibrillation: results from the GARFIELD-AF registry JP Bassand, S Virdone, SZ Goldhaber, AJ Camm, DA Fitzmaurice, ... Circulation 139 (6), 787-798, 2019 | 87* | 2019 |
| Vitamin K antagonist control in patients with atrial fibrillation in Asia compared with other regions of the world: real-world data from the GARFIELD-AF registry S Oh, S Goto, G Accetta, P Angchaisuksiri, AJ Camm, F Cools, S Haas, ... International journal of cardiology 223, 543-547, 2016 | 76 | 2016 |
| Temporal trends in antithrombotic treatment of real-world UK patients with newly diagnosed atrial fibrillation: findings from the GARFIELD-AF registry PN Apenteng, H Gao, FDR Hobbs, DA Fitzmaurice BMJ open 8 (1), e018905, 2018 | 72 | 2018 |
| Management and 1‐year outcomes of patients with newly diagnosed atrial fibrillation and chronic kidney disease: results from the prospective GARFIELD‐AF registry S Goto, P Angchaisuksiri, JP Bassand, AJ Camm, H Dominguez, ... Journal of the American Heart Association 8 (3), e010510, 2019 | 61 | 2019 |
| Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF S Haas, AJ Camm, JP Bassand, P Angchaisuksiri, F Cools, R Corbalan, ... American heart journal 213, 35-46, 2019 | 59 | 2019 |
| Evolving quality standards for large-scale registries: the GARFIELD-AF experience KAA Fox, BJ Gersh, S Traore, A John Camm, G Kayani, A Krogh, ... European Heart Journal–Quality of Care and Clinical Outcomes 3 (2), 114-122, 2017 | 46 | 2017 |
| Analysis of outcomes in ischemic vs nonischemic cardiomyopathy in patients with atrial fibrillation: a report from the GARFIELD-AF registry R Corbalan, JP Bassand, L Illingworth, G Ambrosio, AJ Camm, ... JAMA cardiology 4 (6), 526-548, 2019 | 39 | 2019 |
| Characteristics of patients with atrial fibrillation prescribed antiplatelet monotherapy compared with those on anticoagulants: insights from the GARFIELD-AF registry FWA Verheugt, H Gao, W Al Mahmeed, G Ambrosio, P Angchaisuksiri, ... European heart journal 39 (6), 464-473, 2018 | 38 | 2018 |
| Impact of gender on event rates at 1 year in patients with newly diagnosed non-valvular atrial fibrillation: contemporary perspective from the GARFIELD-AF registry AJ Camm, G Accetta, W Al Mahmeed, G Ambrosio, SZ Goldhaber, S Haas, ... BMJ open 7 (3), e014579, 2017 | 37 | 2017 |
| Outcomes associated with oral anticoagulants plus antiplatelets in patients with newly diagnosed atrial fibrillation KAA Fox, P Velentgas, AJ Camm, JP Bassand, DA Fitzmaurice, BJ Gersh, ... JAMA Network Open 3 (2), e200107-e200107, 2020 | 31 | 2020 |
| Stroke prevention in patients from Latin American countries with non‐valvular atrial fibrillation: insights from the GARFIELD‐AF registry C Jerjes‐Sanchez, R Corbalan, ACP Barretto, HL Luciardi, J Allu, ... Clinical cardiology 42 (5), 553-560, 2019 | 28 | 2019 |
| Treatment patterns in anticoagulant therapy in patients with newly diagnosed atrial fibrillation in Belgium: results from the GARFIELD-AF registry F Cools, B Wollaert, G Vervoort, S Verstraete, J Voet, K Hermans, A Heyse, ... Acta Cardiologica, 2018 | 24 | 2018 |
| Why are outcomes different for registry patients enrolled prospectively and retrospectively? Insights from the global anticoagulant registry in the FIELD-Atrial Fibrillation … KAA Fox, G Accetta, KS Pieper, JP Bassand, AJ Camm, DA Fitzmaurice, ... European Heart Journal-Quality of Care and Clinical Outcomes 4 (1), 27-35, 2018 | 23 | 2018 |
| Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry JPS Sawhney, VA Kothiwale, V Bisne, R Durgaprasad, P Jadhav, ... Indian heart journal 70 (6), 828-835, 2018 | 21 | 2018 |
| Comparison of international normalized ratio audit parameters in patients enrolled in GARFIELD‐AF and treated with vitamin K antagonists DA Fitzmaurice, G Accetta, S Haas, G Kayani, H Lucas Luciardi, ... British journal of haematology 174 (4), 610-623, 2016 | 19 | 2016 |
